A PhD in a scientific discipline and a minimum of 14 years work experience in a research and\/or development environment is required.Post-doctoral work may serve as experience.Equivalent experience may be accepted.Exceptional non-PhDs with demonstrated capabilities and\/or significant experience may also be considered.
The successful candidate must be willing and able to: Demonstrate broad success in technical proficiency, creativity, collaboration with others and independent thought.
Demonstrate a substantial record of technical leadership and contributions of value and a broad range of technical influence.
Represent the leading edge in field, while able to demonstrate expert knowledge in technical principles and concepts both internally and externally with sustained performance and significant accomplishment.
Conduct multi-step organic synthesis for complicated targets.
Demonstrate knowledge and skills to apply advanced chromatographic methods and instrumental analysis to purify and characterize the products.
Demonstrate problem solving capabilities and be able to demonstrate sound judgment.
Demonstrate good understanding and experience of working with water soluble molecules such as PEG, peptides, carbohydrates, etc.is highly desired.
Demonstrate expert knowledge in scientific principles and concepts related to organic chemistry, and must be current with state-of-the-art techniques and literature.
Demonstrate good interpersonal skills, working as a key team member, and previous supervisory skills are a plus.
Clearly communicate scientific information both written and oral with minimal assistance.Good computer skills are required.
We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class. Nektar Therapeutics will consider for employment qualified applicants with criminal histories in the manner proscribed by the San Francisco Fair Chance Ordinance.
Website : http://www.nektar.com
Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.